Atrial Fibrillation Trial, Recruiting NCT07210151 Sponsor: LUMA Vision Ltd. Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07210151
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old at the time of giving consent
  • People who are scheduled to have a catheter ablation procedure to treat atrial flutter or atrial fibrillation (irregular heart rhythms), as recommended by their doctor and in line with current medical guidelines
  • People who are able to understand the study information and are willing to sign a consent form
  • People who are able and willing to attend all required study visits at an approved study location

Who may not be able to join:

  • People for whom the VERAFEYE Imaging Catheter cannot be safely or practically used, as determined by their doctor
  • Women who are pregnant or who plan to become pregnant during the study (at the time of enrolment, women must either be documented as unable to become pregnant, or have had a negative pregnancy test within the 7 days before the procedure)
  • People who have side effects or complications from a previous invasive procedure that have not yet healed or resolved
  • People who have any other planned surgery or procedure involving blood vessels within 30 days before or after the ablation procedure
  • People whose life expectancy is less than 12 months
  • People who currently have a blood clot in the left atrium (upper left chamber of the heart) — a clot check is required within 48 hours before or during the procedure, and if a clot is found, the procedure will not go ahead until a follow-up check confirms the clot is gone (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0894352047

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
LUMA Vision Ltd.
Registry
ClinicalTrials.gov
Start date
29 January 2026
Est. completion
1 November 2026

Where this trial is recruiting

🇭🇷 Croatia 🇨🇿 Czechia

Primary endpoints

Acute procedural success rates during the index procedure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov